It’s a sobering statistic: 1 in 8 women in the United States will be diagnosed with breast cancer during her lifetime.1 ...

The U.S. Food and Drug Administration has approved AstraZeneca and partner Daiichi Sankyo's precision drug to treat a type of ...

The $30 million facility was made possible, in part, through a $4 million contribution through the AdventHealth Palm Coast ...

Danielle Fishel is sharing an update about her health, saying she has completed “active cancer treatment” following her ...

Genetic testing is recommended for those with personal and family histories of several types of cancer — including pancreatic ...

"Boy Meets World" star Danielle Fishel said she is finished with radiation treatment for cancer and opened up about the side ...

Breast cancer is the second leading cause of cancer death in women. Early detection results in 99% five-year survival rates.

AstraZeneca said the U.S. Food and Drug Administration approved Datroway, a treatment for metastatic breast cancer developed in combination with Daiichi Sankyo.

As cancer treatment costs have increased, identifying and treating early-stage cancer sooner reduces expenses and improves ...

One in eight women will suffer from breast cancer in their lifetime. Eight percent will decline treatment due to the fear of alopecia. Regular physical activity prior to a cancer diagnosis lowered ...

recognizing the symptoms of breast cancer early may result in earlier treatment and a better outlook. A breast lump may be easier to feel than see, but there are some characteristic ways breast ...

Datroway has been approved for unresectable or metastatic HR+, HER2- breast cancer after endocrine therapy and chemotherapy.